Biosynthesis method for directly converting HCABAs into UDCA, acquisition method and application

Through anaerobic incubation of chyme with HCA_BAs or CDCA, it is directly converted into UDCA, solving the problem of instability of mycozyme, improving catalytic efficiency, broadening the basis of UDCA biosynthesis, and providing more efficient and more efficient for industrial production. A stable path.

CN118957013APending Publication Date: 2024-11-15FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411034289.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

In the existing UDCA biosynthesis methods, mycozyme 7α/β-HSDH is unstable, has low catalytic efficiency, and is difficult to withstand high concentrations of substrates, which limits the development of biocatalytic synthesis of UDCA.

Method used

By mixing anaerobic incubation with HCA_BAs or CDCA under anaerobic conditions with chyme from flower bass, it is directly converted to UDCA, avoiding the dependence on 7α/β-HSDH, and enriching the intestinal function microbiome, especially the shuttle, For the phylum Bacillus, HCA_BAs are preferred to convert to UDCA.

Benefits of technology

It improves the catalytic efficiency and stability of UDCA, broadens the microbiological basis of biosynthesis, and provides a more efficient and stable choice for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118957013A_ABST
    Figure CN118957013A_ABST
Patent Text Reader

Abstract

The invention provides a biosynthesis method, an acquisition method and application for directly converting hyocholic acid (HCABA) into ursodesoxycholic acid (UDCA). The biosynthesis method of UDCA comprises the following steps: breeding lateolabrax japonicus with feed, and then obtaining chyme of lateolabrax japonicus; mixing the obtained chyme of the lateolabrax japonicus with a first bile acid solution, and performing anaerobic incubation under an anaerobic condition; terminating the incubation, and separating the product of the anaerobic incubation to obtain UDCA; and the first bile acid is HCABAs or CDCA. According to the method, chyme of lateolabrax japonicus is incubated through bile acid (HCABAs or CDCA), and the HCABAs can be converted into UDCA. Meanwhile, the conversion of the HCABAs to the UDCA does not depend on 7alpha-HSDH and 7beta-HSDH, so that the problem that the bacterial enzyme 7alpha / beta-HSDH in the existing biosynthesis method is unstable is avoided, and a new insight and direction are provided for biosynthesis of the UDCA.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of ursodeoxycholic acid (UDCA) biosynthesis, and specifically relates to a biosynthesis method, an acquisition method and an application of UDCA by directly converting HCA_BAs into UDCA. Background Art

[0002] Ursodeoxycholic acid (UDCA), also known as 3α, 7β-dihydroxy-5β-cholestane-24-acid, is a hydrophilic bile acid with multiple biological activities, wide clinical applications and excellent medicinal value. As the only clinical drug approved by the FDA for the treatment of primary bile acid cirrhosis, UDCA can promote bile acid synthesis, reduce cholesterol saturation, dissolve gallstones, improve cholestasis, maintain enterohepatic bile acid metabolic homeostasis, and protect liver cells from harmful bile acid damage. In addition, UDCA has also shown good efficacy in the treatment of cancer and new crowns. Compared with chenodeoxycholic acid CDCA, UDCA is less toxic to the liver, has fewer side effects with long-term use, and has broad application prospects.

[0003] At present, the preparation methods of UDCA include animal bile drainage, chemical synthesis and biocatalytic synthesis. Bile drainage mainly relies on live bears, but it is not recommended because of its limited source and violation of animal protection laws and humanitarian principles. Chemical synthesis mainly uses CA, CDCA and HCA_BAs (pig bile acid) rich in livestock and poultry bile as raw materials, and synthesizes UDCA through a series of chemical reaction steps such as hydroxylation, methyl esterification, hydroxyl configuration inversion, Mozingo reduction and Wolff-Kishner reaction. However, these synthetic pathways are relatively cumbersome, the product purity is low, the production cost is high, and the use of toxic reagents and the generation of toxic by-products in the process pollute the environment. In addition, the high temperature, high pressure and other dangerous operations involved increase the risk and difficulty of industrial production. These factors make the chemical synthesis of UDCA face significant adjustments in large-scale production, and it is necessary to optimize the process or find other ways to improve efficiency and safety. In recent years, the biosynthesis technology of UDCA has made rapid progress. Compared with chemical synthesis, biocatalysis has the characteristics of green, high efficiency and safety, and is the current research hotspot and difficulty in the preparation of UDCA. The key to biocatalytic synthesis of UDCA is to select appropriate enzymes, among which the most critical are the bacterial enzymes 7α-HSDH and 7β-HSDH secreted by microorganisms. Through the catalytic action of these two enzymes, CDCA can be converted into UDCA through a two-step reaction. The Chinese patent document with publication number CN112852652A discloses a recombinant yeast strain, construction and application for efficiently converting chenodeoxycholic acid to synthesize ursodeoxycholic acid. The 7α-HSDH and 7β-HSDH encoding genes of Clostridium are heterologously expressed in the saccharomyces cerevisiae CEN.PK2-1C as the chassis cell, and CDCA is biosynthesized as a substrate. UDCA. The Chinese patent document with publication number CN117535217A discloses a recombinant Bacillus subtilis engineering strain and its application in the biological preparation of ursodeoxycholic acid. The recombinant Bacillus subtilis engineering strain can efficiently and stably biosynthesize ursodeoxycholic acid. However, the above-mentioned biosynthesis process has extremely high requirements on the strain, and it is necessary to reorganize or encode bacteria and bacterial enzymes, etc., which has high technical requirements and is unstable. The currently used bacterial enzymes, especially 7β-HSDH, have poor stability, are rapidly inactivated in the reaction system, and are difficult to withstand high concentrations of substrates, resulting in low catalytic efficiency, which seriously restricts the development of biocatalytic synthesis of UDCA. Therefore, it is of great significance to explore new biosynthetic pathways. Summary of the invention

[0004] The technical problem solved by the present invention is to provide a biosynthesis method, an acquisition method and an application of directly converting HCA_BAs into UDCA. The Lateolabrax chyme can be first converted into CDCA using HCA_BAs, and then converted into UDCA; at the same time, HCA_BAs can also be directly converted into UDCA under the action of relevant functional bacteria such as Fusobacteria, without going through the intermediate step of CDCA, which not only avoids the problem of instability of bacterial enzyme 7α / β-HSDH, but also provides new insights and directions for the biosynthesis of UDCA.

[0005] In order to solve the above problems, the first aspect of the present invention provides a biosynthetic method for directly converting HCA_BAs into UDCA, comprising the following steps:

[0006] The japonica seabass is cultured with feed, and then the japonica seabass chyme is obtained; the japonica seabass chyme obtained is mixed with a first bile acid solution, and anaerobically incubated under anaerobic conditions; the incubation is terminated, and the product of the anaerobic incubation is separated to obtain UDCA; wherein the first bile acid is HCA_BAs or CDCA.

[0007] Preferably, the feed contains 0.03% to 0.15% by mass of the second bile acid; the second bile acid is one or a mixture of HCA_BAs and CDCA.

[0008] Preferably, the second bile acid comprises HCA_BAs and CDCA, the mass percentage of HCA_BAs is 70% to 85%, and the mass percentage of CDCA is 15% to 25%.

[0009] Preferably, the step of mixing the obtained Lateolabrax chyme with the first bile acid solution and incubating the mixture anaerobically under anaerobic conditions specifically comprises the following steps:

[0010] The obtained chyme of sea bass is placed in an anaerobic fermentation bottle, and sterile water is added for homogenization to obtain a homogenate sample; the first bile acid solution is added to the homogenate sample to make the concentration of the first bile acid solution 1-10 mM; anaerobically incubated at 22-27° C. for 0.5-12 hours under anaerobic conditions.

[0011] Preferably, during the anaerobic incubation, the anaerobic fermentation bottle is placed on a shaker for shaking, and the shaking speed is 100-150 rpm.

[0012] Preferably, when the chyme obtained by culturing Lateolabrax japonicus with a feed containing the second bile acid is subjected to anaerobically incubated for 3 to 12 hours, and when the chyme obtained by culturing Lateolabrax japonicus with a feed not containing the second bile acid is subjected to anaerobically incubated for 0.5 to 3 hours.

[0013] Preferably, the terminating the incubation and separating the product of the anaerobic incubation specifically comprises the following steps:

[0014] Sodium hydroxide was added to the product of anaerobic incubation, and water was added after shaking and mixing. After shaking, the product was centrifuged in a centrifuge, the supernatant was collected, and then UDCA was extracted.

[0015] A second aspect of the present invention provides a method for obtaining UDCA, comprising the following steps:

[0016] The method comprises the following steps: breeding japonicus with a feed containing a second bile acid, obtaining the japonicus chyme, separating the obtained chyme, and obtaining UDCA; the feed contains 0.03% to 0.15% by mass of the second bile acid; and the second bile acid is a mixture of one or both of HCA_BAs and CDCA.

[0017] Preferably, the method further comprises: after culturing the Lateolabrax japonicus with the feed containing the second bile acid, administering HCA_BAs to the Lateolabrax japonicus.

[0018] The third aspect of the present invention provides a use of Lateolabrax japonicus chyme or Fusobacterium in the preparation of UDCA.

[0019] Compared with the prior art, the present invention has the following beneficial effects:

[0020] The present invention utilizes the chyme of the japonica seabass to incubate bile acid (HCA_BAs or CDCA) to convert HCA_BAs into UDCA. Meanwhile, the conversion of HCA_BAs into UDCA does not depend on 7α-HSDH and 7β-HSDH, and after eating feed containing HCA_BAs, the japonica seabass is more inclined to preferentially utilize HCA_BAs to convert into UDCA.

[0021] The present study found that after eating feed containing HCA_BAs, the functional microbial community in the intestine of the striped seabass, especially the abundance of Fusobacteria microorganisms, can be enriched. The striped seabass is more inclined to preferentially utilize HCA_BAs to convert into UDCA rather than CDCA, which further promotes the conversion of HCA_BAs to UDCA, thereby increasing the body's UDCA level.

[0022] The present invention is the first to use Lateolabrax japonicus to convert HCA_BAs into CDCA, and can also use Lateolabrax japonicus to directly convert HCA_BAs into UDCA.

[0023] The new biosynthetic pathway provided by the present invention not only broadens the microbiological basis for UDCA production, but also provides more options and flexibility for industrial production. Future research can further optimize the functions of these microorganisms, improve conversion efficiency, and explore more possible microorganisms and enzyme systems to achieve more efficient and stable UDCA production. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 is the bile acid profile of the foregut and hindgut chyme of Lateolabrax japonicus in Example 1 of the present invention;

[0025] Figure 2 The bile acid conversion in the intestinal chyme of the Lateolabrax japonicus that had eaten the bile acid-containing feed in Example 2 of the present invention after being gavage-administered with d5_HCA_BAs;

[0026] Figure 3 The effects of HCA_BAs and CDCA on 7α / β-HSDH and UDCA in intestinal chyme in Example 3 of the present invention, wherein (A)-(C) the production of 7α-HSDH, 7β-HSDH and UDCA in chyme after incubation with HCA_BAs under different diets (PPB and PPB+BA groups). (D)-(F) the production of 7α-HSDH, 7β-HSDH and UDCA in chyme after incubation with HCA_BAs or CDCA under bile acid diet conditions;

[0027] Figure 4 is the abundance of Fusobacterium chymogenes in the intestinal tract of different treatment groups in Example 4 of the present invention;

[0028] Figure 5 This is the correlation analysis between Fusobacteria and UDCA-type bile acids in Example 4 of the present invention. DETAILED DESCRIPTION

[0029] The following will be combined with the embodiments of the present invention to clearly and completely describe the technical solution of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] A first aspect of an embodiment of the present invention provides a biosynthetic method for directly converting HCA_BAs into UDCA, comprising the following steps:

[0031] The japonica seabass is cultured with feed, and then the japonica seabass chyme is obtained; the japonica seabass chyme obtained is mixed with a first bile acid solution, and anaerobically incubated under anaerobic conditions; the incubation is terminated, and the product of the anaerobic incubation is separated to obtain UDCA; wherein the first bile acid is HCA_BAs or CDCA.

[0032] The present invention is the first to study and find that bile acid (HCA_BAs or CDCA) can be converted into UDCA by incubating bile acid (HCA_BAs or CDCA) with the chyme of Lateolabrax japonicus. The conversion of HCA_BAs to UDCA does not depend on 7α-HSDH and 7β-HSDH, and after eating feed containing HCA_BAs, Lateolabrax japonicus prefers to preferentially use HCA_BAs to convert into UDCA.

[0033] Preferably, the feed contains 0.03% to 0.15% by mass of the second bile acid; the second bile acid is a mixture of one or both of HCA_BAs and CDCA. The present invention has found that after eating feed containing HCA_BAs, the functional microbial community in the intestine of the sea bass, especially the abundance of Fusobacteria microorganisms, can be enriched. The sea bass is more inclined to preferentially use HCA_BAs to convert into UDCA rather than CDCA, which further promotes the conversion of HCA_BAs to UDCA, thereby increasing the body's UDCA level.

[0034] Preferably, the second bile acid comprises HCA_BAs and CDCA; the mass percentage of HCA_BAs is 70% to 85%; the mass percentage of CDCA is 15% to 25%.

[0035] Preferably, the step of mixing the obtained Lateolabrax chyme with the first bile acid and incubating the mixture anaerobically under anaerobic conditions specifically comprises the following steps:

[0036] The obtained chyme of sea bass is placed in an anaerobic fermentation bottle, and sterile water is added for homogenization to obtain a homogenate sample; the first bile acid solution is added to the homogenate sample, and 0.01-0.1 mL of the first bile acid solution is added to each 10 mg of chyme, so that the concentration of the first bile acid solution is 1-10 mM; anaerobically incubated at 22-27° C. for 0.5-12 h under anaerobic conditions. The temperature conditions of the incubation process imitate the ambient temperature of the fish body. Preferably, the anaerobic incubation is performed at 26° C. Preferably, the concentration of the first bile acid solution is 5 mM.

[0037] Preferably, during anaerobic incubation, the anaerobic fermentation bottle is also placed on a shaker for shaking, and the shaking speed is 100-150 rpm. In the process of simulating intestinal anaerobic fermentation using the anaerobic fermentation bottle and the anaerobic box, it is necessary to keep the solution in the anaerobic fermentation bottle moderately shaken. To this end, the anaerobic fermentation box is placed on a shaker for shaking.

[0038] Preferably, the chyme obtained by breeding Lateolabrax japonicus with feed containing bile acid is anaerobically incubated for 3 to 12 hours, more preferably, for 12 hours; the chyme obtained by breeding Lateolabrax japonicus with feed not containing bile acid is anaerobically incubated for 0.5 to 3 hours, more preferably, for 3 hours.

[0039] Preferably, the terminating the incubation and separating the product of the anaerobic incubation specifically comprises the following steps:

[0040] Sodium hydroxide was added to the product of anaerobic incubation, and water was added after shaking and mixing. After shaking, the product was centrifuged in a centrifuge, the supernatant was collected, and then UDCA was extracted.

[0041] Specifically, the steps include:

[0042] 100 μL of 0.2 mM sodium hydroxide was added to 200 μL of the homogenate sample of the anaerobic incubation product, and 1 mL of 4°C water was added after thorough shaking and mixing. After shaking, the mixture was centrifuged at 10,000 rpm in a 4°C centrifuge for 20 min, the supernatant was collected, and then UDCA was extracted.

[0043] Specifically, the steps of extracting UDCA are as follows: transfer the supernatant to a centrifuge tube, add 0.9 mL of 75% anhydrous ethanol, and fully shake to extract bile acid. After mixing, place the centrifuge tube in a 4°C centrifuge, centrifuge at 15,000 rpm for 10 min, transfer 0.5 mL of supernatant to a new 2 mL centrifuge tube, add 0.5 mL of pre-cooled ice acetonitrile, vortex mix, centrifuge at 15,000 rpm for 10 min (4°C), and after centrifugation, pass the supernatant through a 0.2 μm filter membrane into an automatic injection bottle for detection on the machine.

[0044] A second aspect of the present invention provides a method for obtaining UDCA, comprising the following steps:

[0045] The method comprises the following steps: breeding japonicus with feed containing bile acid, obtaining chyme of the japonicus, separating the obtained chyme and obtaining UDCA; the feed contains bile acid with a mass percentage of 0.03% to 0.15%; and the bile acid is a mixture of one or both of HCA_BAs and CDCA.

[0046] The present invention is the first to discover that Lateolabrax japonicus can utilize HCA_BAs to directly convert into UDCA.

[0047] Preferably, the method further comprises: after the Lateolabrax japonicus is cultured with feed containing bile acid, administering HCA_BAs to the Lateolabrax japonicus.

[0048] The third aspect of the present invention provides a use of Lateolabrax japonicus chyme or Fusobacterium in the preparation of UDCA.

[0049] The present invention found that the japonica seabass chyme can convert HCA_BAs into UDCA, and experiments have shown that the intestinal microbial flora dominated by Fusobacteria plays an important role in the conversion of HCA_BAs to UDCA and promotes the conversion process. Specifically, japonica seabass can use HCA_BAs to first convert into CDCA, and then into UDCA. At the same time, HCA_BAs can also be directly converted into UDCA under the action of related functional flora such as Fusobacteria, without going through the intermediate step of CDCA. Therefore, this application not only avoids the problem of instability of the bacterial enzyme 7α / β-HSDH, but also provides new insights and directions for the biosynthesis of UDCA.

[0050] Example 1: The content of UDCA bile acid in the body of sea bass was increased by feeding on feed containing HCA_BAs

[0051] The experiment designed two kinds of isonitrogen and isolipid feeds (see Table 1 for feed formula), named PPB and PPB+BA. The PPB group was supplemented with 10% fish meal, 15% cottonseed protein concentrate, 10% U.S. soybean meal and 27% soybean protein concentrate, and the PPB+BA group was supplemented with 0.15% bile acid (including 80% hyobolic acid and 20% chenodeoxycholic acid) on the basis of the PPB group. The feed raw materials were stirred and mixed step by step in the order of small to large addition, and a twin-screw extruder was used to make 3mm extruded floating granular feed, which was naturally dried and stored at -20℃ until use. The experiment selected healthy and uniform-sized Lateolabrax (41.7±0.01g) and randomly assigned them to 8 breeding barrels, with 30 fish in each barrel, and every four barrels as a treatment group. An 8-week breeding experiment was carried out, and the apparent satiation was fed twice a day.

[0052] After the entire breeding experiment was completed, the Lateolabrax were starved for 4 h, 4 fish were selected from each bucket and anesthetized with 0.3 g / mL of chlorobutanol, and the chyme of the fore and hind intestines of each fish was collected in a sterile environment and stored at -80°C for microbial and bile acid detection.

[0053] The pretreatment and detection steps of bile acid in the fore and hind intestine chyme refer to the "Qualitative and quantitative detection method of bile acid in multiple tissues by liquid chromatography high-resolution mass spectrometry" (patent number CN202111636454.4).

[0054] By testing the bile acid profile of the anteroposterior and posterior intestinal chyme, such as Figure 1, it was found that the bile acid in the body of striped sea bass was mainly in the form of taurine binding, among which TCA was the main component, and the proportion of TCA in both groups was more than 96%, followed by TCDCA (1.56% and 2.40%, respectively). In the foregut chyme, compared with the PPB group, in addition to the significant increase in the content of HCA_BAs added to the feed in the PPB+BA group, the content of UDCA-type bile acids (UDCA_BAs; including UDCA, TUDCA and GUDCA) also increased significantly, and even TUDCA accounted for 0.647% of the bile acid in the foregut chyme of the PPB+BA group. The results of bile acid detection in the hindgut chyme were consistent with the research results in the foregut chyme. The difference is that the content of HCA_BAs in the hindgut chyme of the PPB+BA group was also significantly increased, accounting for 3.52% in the PPB+BA group, which was not detected in the PPB group. Therefore, it can be considered that the increased UDCA in the body of striped sea bass is converted from HCA_BAs.

[0055] Table 1 Feed formula and nutritional composition (%)

[0056]

[0057]

[0058] Example 2: Lateolabrax can be converted into UDCA using HCA_BAs

[0059] In order to verify that the elevated UDCA in Lateolabrax was converted from HCA_BAs, the following experiment was conducted.

[0060] Ten Lateolabrax japonicus that had been fed with bile acid feed were randomly selected and assigned to one culture barrel. Each fish was gavaged with d5_HCA_BAs (specific dose was 50 ng / g body weight), and intestinal chyme was collected 3 hours after gavage for bile acid detection.

[0061] The results of the study show that ( Figure 2 ), d5_CDCA_BAs and d5_UDCA_BAs were detected in the intestinal chyme of Lateolabrax japonicus after oral administration of d5_HCA_BAs, proving that HCA_BAs can be converted into CDCA and UDCA.

[0062] Example 3

[0063] In view of the fact that CDCA can be converted into UDCA, the following bile acid in vitro incubation test was performed to verify whether UDCA is first converted into CDCA via HCA_BAs and then converted through the CDCA pathway, or is directly converted from HCA_BAs.

[0064] Bile acid in vitro incubation test: Collect the intestinal chyme of PPB and PPB+BA groups of sea bass after the breeding test in Example 1, with 9 fish in each group. After mixing the intestinal chyme of each fish, 10 mg of chyme was placed in a 5 mL anaerobic fermentation bottle, and 200 μL of 4°C water was added to each bottle for homogenization to prepare a homogenate sample. Bile acids (including HCA_BAs and CDCA) were added to a final concentration of 5 mM. The fermentation bottle was placed in an anaerobic fermentation box and incubated anaerobically under anaerobic conditions at 26±2°C. The test was terminated after 0, 0.5, 3 and 12 hours of incubation. The termination operation steps were: 100 μL of 0.2 mmol / L sodium hydroxide was added to each bottle, 1 mL of 4°C water was added after sufficient shaking and mixing, and centrifuged after shaking (10000 rpm, 4°C, 20 min). The supernatant was collected and stored at -80°C for subsequent bile acid extraction and analysis.

[0065] The results show that Figure 3 ), under HCA_BAs culture conditions, compared with the PPB group, the production of 7α-HSDH and 7β-HSDH in the PPB+BA group decreased significantly after 12 hours of incubation, while the production of UDCA increased significantly. In addition, in the digesta of the PPB+BA group, compared with the CDCA incubation conditions, under HCA_BAs incubation conditions, the production of 7α-HSDH and 7β-HSDH decreased significantly after 12 hours of incubation, while the production of UDCA increased significantly. These two results combined indicate that the conversion of HCA_BAs to UDCA does not depend on 7α-HSDH and 7β-HSDH, and after eating feed containing HCA_BAs, Lateolabrax ocellaris prefers to use HCA_BAs to convert into UDCA rather than CDCA.

[0066] Example 4 Fusobacterium group is conducive to the conversion of HCA_BAs to UDCA

[0067] The above experimental research results have proved that Lateolabrax japonicus can directly convert HCA_BAs into UDCA, in which intestinal microorganisms play a vital role. In order to clarify the types of flora that play an important role, the intestinal chyme collected in Example 1 was subjected to metagenomic detection.

[0068] The results showed that the abundance of Fusobacteria in the PPB+BA group was significantly increased compared with the PPB group ( Figure 4 ), and Fusobacteria was significantly positively correlated with UDCA_BAs ( Figure 5), indicating that the increase of UDCA in the PPB+BA group was closely related to the increase of Fusobacteria abundance. This shows that the intestinal microbial flora dominated by Fusobacteria plays an important role in the conversion of HCA_BAs to UDCA and promotes this conversion process.

[0069] Example 5

[0070] The biosynthetic method of UDCA of this embodiment comprises the following steps:

[0071] 1. An 8-week breeding experiment was conducted on Lateolabrax japonicus using the PPB+BA group of feed in Table 1 of Example 1, with the Lateolabrax japonicus being fed twice a day at an apparent satiation rate.

[0072] 2. Obtain the chyme of the sea bass. After 3 hours of feeding, each fish was anesthetized with chlorobutanol. After the fish was anesthetized, 75% alcohol was used to soak the gauze, and the fish body was wiped with the gauze containing alcohol to sterilize it. Then the fish was quickly placed in the clean bench. In the clean bench, sterilized surgical scissors were used to cut open the abdomen of the fish along the anus, and the visceral mass was obtained aseptically, and the entire intestinal segment containing the chyme was collected. The entire intestinal segment containing the chyme was cut open longitudinally with surgical scissors, and the chyme of the entire intestinal segment was scraped.

[0073] 3. The collected intestinal chyme of Leptotrus japonicus was fully mixed, 10 mg of chyme was weighed and placed in a 5 mL anaerobic fermentation bottle, and 200 μL of 4°C sterile water was added for homogenization to prepare a homogenate sample. Bile acid solutions (HCA_BAs solution and CDCA solution) were added to the anaerobic fermentation bottles, and the concentration of the bile acid solution was 5 mM; after the homogenate containing chyme and the bile acid solution were fully mixed, the anaerobic fermentation bottle was placed in an anaerobic fermentation box, the temperature in the fermentation box was set to 26°C, and the anaerobic fermentation box was placed on a shaker, and the speed was set to 100-150 rpm.

[0074] 4. The test was terminated after 12 hours of anaerobic incubation. The termination steps were as follows: 100 μL of 0.2 mM sodium hydroxide was added to the 200 μL homogenate sample system, and 1 mL of 4°C water was added after sufficient shaking and mixing. After shaking, the mixture was centrifuged at 10,000 rpm in a 4°C centrifuge for 20 min, and the supernatant was collected for bile acid extraction and bacterial enzyme detection.

[0075] Example 6

[0076] The remaining steps of the UDCA biosynthesis method of this example are the same as those in Example 5, except that the experiment is terminated after 0.5 h of anaerobic incubation.

[0077] Example 7

[0078] The remaining steps of the UDCA biosynthesis method of this example are the same as those in Example 5, except that the experiment is terminated after the 3rd hour of anaerobic incubation.

[0079] Example 8

[0080] The remaining steps of the UDCA biosynthesis method of this example are the same as those in Example 5, except that the concentration of the bile acid solution is 1 mM.

[0081] Example 9

[0082] The remaining steps of the UDCA biosynthesis method of this example are the same as those in Example 5, except that the concentration of the bile acid solution is 10 mM.

[0083] Example 10

[0084] The remaining steps of the UDCA biosynthesis method of this embodiment are the same as those in Embodiment 5, except that the temperature in the fermentation chamber is 22°C.

[0085] Embodiment 11

[0086] The remaining steps of the UDCA biosynthesis method of this embodiment are the same as those in Embodiment 5, except that the temperature in the fermentation chamber is 27° C.

[0087] Example 12

[0088] The remaining steps of the UDCA biosynthesis method of this embodiment are the same as those in Implementation 5, except that the feed of the PPB group in Example 1 is used to culture the Lateolabrax japonicus.

[0089] The yields of the UDCA biosynthesis methods of the above examples are shown in Table 2 below.

[0090] Table 2

[0091] UDCA yield (%) Example 5 127% Example 6 98% Example 7 115% Example 8 127% Example 9 151% Example 10 114% Embodiment 11 144% Example 12 62%

[0092] Obviously, the above embodiments are merely examples for the purpose of clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived therefrom are still within the scope of protection of the invention.

Claims

1. A biosynthetic method for directly converting HCA_BAs into UDCA, characterized in that: The following steps are involved: The japonica seabass is cultured with feed, and then the japonica seabass chyme is obtained; The obtained Lateolabrax chyme is mixed with the first bile acid solution, and anaerobically incubated under anaerobic conditions; the incubation is terminated, and the product of the anaerobic incubation is separated to obtain UDCA; wherein the first bile acid is HCA_BAs or CDCA.

2. The biosynthetic method of directly converting HCA_BAs into UDCA according to claim 1, characterized in that: The feed contains 0.03% to 0.15% by mass of the second bile acid; the second bile acid is a mixture of one or both of HCA_BAs and CDCA.

3. The biosynthetic method of directly converting HCA_BAs into UDCA according to claim 2, characterized in that: The second bile acid includes HCA_BAs and CDCA, the mass percentage of HCA_BAs is 70% to 85%, and the mass percentage of CDCA is 15% to 25%.

4. The biosynthetic method of directly converting HCA_BAs into UDCA according to claim 1, characterized in that: The step of mixing the obtained Lateolabrax chyme with the first bile acid solution and incubating the mixture anaerobically under anaerobic conditions specifically comprises the following steps: The obtained chyme of sea bass is placed in an anaerobic fermentation bottle, and sterile water is added for homogenization to obtain a homogenate sample; the first bile acid solution is added to the homogenate sample to make the concentration of the first bile acid solution 1-10 mM; anaerobically incubated at 22-27° C. for 0.5-12 hours under anaerobic conditions.

5. The biosynthetic method of directly converting HCA_BAs into UDCA according to claim 4, characterized in that: During the anaerobic incubation, the anaerobic fermentation bottle is also placed on a shaker for shaking, and the shaking speed is 100-150 rpm.

6. The biosynthetic method of directly converting HCA_BAs into UDCA according to claim 4, characterized in that: When the chyme obtained by breeding the Lateolabrax japonicus with a feed containing the second bile acid is incubated anaerobically for 3 to 12 hours; when the chyme obtained by breeding the Lateolabrax japonicus with a feed not containing the second bile acid is incubated anaerobically for 0.5 to 3 hours.

7. The biosynthetic method of directly converting HCA_BAs into UDCA according to claim 1, characterized in that: The terminating the incubation and separating the product of the anaerobic incubation specifically comprises the following steps: Sodium hydroxide was added to the product of anaerobic incubation, and water was added after shaking and mixing. After shaking, the product was centrifuged in a centrifuge, the supernatant was collected, and then UDCA was extracted.

8. A method for obtaining UDCA, characterized in that: The following steps are involved: The method comprises the following steps: breeding japonicus with a feed containing a second bile acid, obtaining the japonicus chyme, separating the obtained chyme, and obtaining UDCA; the feed contains 0.03% to 0.15% by mass of the second bile acid; and the second bile acid is a mixture of one or both of HCA_BAs and CDCA.

9. The method for obtaining UDCA according to claim 8, characterized in that: Also includes: After the Lateolabrax japonicus was cultured with a feed containing the second bile acid, HCA_BAs were administered orally to the Lateolabrax japonicus.

10. Use of Lateolabrax japonicus chyme or Fusobacterium in the preparation of UDCA.

Citation Information

Patent Citations

  • Recombinant yeast strain for efficiently converting chenodeoxycholic acid to synthesize ursodeoxycholic acid, and construction and application of recombinant yeast strain

    CN112852652A

  • Liquid chromatography high resolution mass spectrometry qualitative and quantitative detection method for bile acid in multiple tissues

    CN114509513A

  • Recombinant bacillus subtilis engineering strain and application thereof in biological preparation of ursodesoxycholic acid

    CN117535217A